QIC Global and Bluewolf are the same company.
QIC Global and Bluewolf are the same company.
By: Bluewolfcerts | Published on: March 25, 2026
Regulatory scrutiny and product reliability accompany each other in the case of in vitro diagnostic (IVD) manufacturers. Since the reagents and instruments are not the only items that will be introduced into the healthcare market, each of the products has to be of excellent quality and safety. The ISO 13485 for IVD manufacturers gives a structured quality management framework whereby control and traceability, and documented evidence are stressed throughout the product lifecycle.
Documentation is the most prominent requirement of ISO 13485. Poorly maintained documents form the largest number of reasons, which manufacturers find themselves caught up in an audit or delayed certification. Understanding the importance of the documents that are of greatest importance is vital in attaining compliance and sustaining it.
ISO 13485 is a standard that is documentation-based. To the manufacturers of IVDs, records reveal that procedures are set, risks are addressed, and that products are always used according to their intended purposes, and in accordance with the regulations.
The right documentation assists organizations:
Even technically sound manufacturing systems might not meet the ISO 13485 expectations without proper documentation.
The quality manual describes the level of the quality management system, exclusions, when applicable, and process interactions. To the IVD manufacturers, it must explicitly identify such product categories as reagents, instruments, or diagnostic software.
The quality policy should demonstrate dedication to compliance with the regulations, product safety, and constant improvement.
The ISO 13485 demands strict regulation of documents and records. This will be version control, approval status, distribution, retention period, and protection against unintentional changes.
The manufacturers of IVD have to record the way design activities will be managed and scheduled. This involves responsibilities, review, verification, and validations.
Design input forms help in recording the intended use, performance requirements, and regulatory requirements. Design outputs are specifications, drawings, formulations, or code of software.
The formal design reviews will have to be documented to ensure that the outputs are as per the input and that risks are taken care of.
IVD products should have risk management documentation because of the influence on clinical decisions. The files are supposed to determine the hazards, estimate the risks, establish the measures of control, and record the residual risks.
These records should be upgraded throughout the product lifecycle and updated by the changes that come.
The processes of manufacturing, assembling, testing, and packaging of IVD products should be documented. This guarantees consistency and reduces fluctuations in the production batches.
The processes that cannot be checked completely with the help of inspection, i.e., sterilization, software, reagent formulation, etc., should be validated. Audit evidence that is important is validation protocols and results.
IVD manufacturers are dependent on suppliers as sources of raw materials, parts, and services. The ISO 13485 specifies written standards of selection, vetting, and re-vetting of suppliers.
These records exhibit the management of the external processes that influence the quality of products.
Manufacturers are obligated to write down how they receive, assess, investigate, and dispose of customer complaints. In the case of IVD products, this is strongly connected with patient safety and regulatory reporting standards.
CAPA records are also used to record the analysis of nonconformities, identification of root causes, and the implementation of actions to avoid repeating nonconformities.
| Document Type | Purpose | Why It Matters |
| Quality Manual | Defines QMS structure | Demonstrates system-wide control |
| Design Records | Controls product development | Ensures safety and performance |
| Risk Management Files | Identifies and mitigates risks | Protects patients and users |
| Process Validation Records | Confirms process reliability | Reduces batch variability |
| Supplier Records | Controls external inputs | Ensures consistent quality |
| CAPA Records | Addresses nonconformities | Supports continual improvement |
Implementation of ISO 13485 for IVD manufacturers is not merely about having a process in place, but about demonstrating the processes by doing so with correct, comprehensive, and controlled documents. A story of how quality and safety are ensured is found in every document, be it design and risk management or production and post-market activities. The correctness of this documentation enhances confidence in the regulators, increases the results of audits, and promotes long-term product reliability. Blue Wolf Certifications can be used as a certification body by organizations that want to achieve ISO 13485 certification to ensure conformity assessment and proof of compliance with international quality management requirements independently.
Yes, it is acceptable to keep electronic documentation provided that access, security, versioning, and traceability are well taken care of.
At least the lifetime of the IVD product, or what the applicable regulations demand, should be held in records.
Yes, the ISO 13485 mandates a risk management that is documented on all medical equipment, including IVDs.
Yes, software validation and version control records, and records on cybersecurity are particularly crucial to software-based IVDs.
Yes, this is one of the reasons why nonconformities to audits and postponement of certification are common results of incomplete or incongruent documentation.
